We propose a semiparametric latent Gaussian copula model for modelling mixed multivariate data, which contain a combination of both continuous and binary variables. The model assumes that the observed binary variables are obtained by dichotomizing latent variables that satisfy the Gaussian copula distribution. The goal is to infer the conditional independence relationship between the latent random variables, based on the observed mixed data. Our work has two main contributions: we propose a unified rankbased approach to estimate the correlation matrix of latent variables; we establish the concentration inequality of the proposed rankbased estimator. Consequently, our methods achieve the same rates of convergence for precision matrix estimation and graph recovery, as if the latent variables were observed. The methods proposed are numerically assessed through extensive simulation studies, and real

This article studies estimation of partially linear hazard regression models for multivariate survival data. A profile pseudopartial likelihood estimation method is proposed under the marginal hazard model framework. The estimation on the parameters for the linear part is accomplished by maximization of a pseudopartial likelihood profiled over the nonparametric part. This enables us to obtain-consistent estimators of the parametric component. Asymptotic normality is obtained for the estimates of both the linear and nonlinear parts. The new technical challenge is that the nonparametric component is indirectly estimated through its integrated derivative function from a local polynomial fit. An algorithm of fast implementation of our proposed method is presented. Consistent standard error estimates using sandwich-type ideas are also developed, which facilitates inferences for the model. It is shown that the

We propose a novel technique to boost the power of testing a highdimensional vector <i>H</i>:<i><b></b></i>=<b>0</b> against sparse alternatives where the null hypothesis is violated by only a few components. Existing tests based on quadratic forms such as the Wald statistic often suffer from low powers due to the accumulation of errors in estimating highdimensional parameters. More powerful tests for sparse alternatives such as thresholding and extreme value tests, on the other hand, require either stringent conditions or bootstrap to derive the null distribution and often suffer from size distortions due to the slow convergence. Based on a screening technique, we introduce a power enhancement component, which is zero under the null hypothesis with high probability, but diverges quickly under sparse alternatives. The proposed test statistic combines the power enhancement component with an asymptotically pivotal statistic, and

<b></b> Estimation of the covariance structure of longitudinal processes is a fundamental prerequisite for the practical deployment of functional mapping designed to study the genetic regulation and network of quantitative variation in dynamic complex traits. We present a nonparametric approach for estimating the covariance structure of a quantitative trait measured repeatedly at a series of time points. Specifically, we adopt Huang et al.'s (2006,<i>Biometrika</i><b>93</b>, 8598) approach of invoking the modified Cholesky decomposition and converting the problem into modeling a sequence of regressions of responses. A regularized covariance estimator is obtained using a normal penalized likelihood with an<i>L</i>₂ penalty. This approach, embedded within a mixture likelihood framework, leads to enhanced accuracy, precision, and flexibility of functional mapping while preserving its biological relevance. Simulation studies are

This paper discusses statistical methods for estimating complex correlation structure from large pharmacogenomic datasets. We selectively review several prominent statistical methods for estimating large covariance matrix for understanding correlation structure, inverse covariance matrix for network modeling, large-scale simultaneous tests for selecting significantly differently expressed genes and proteins and genetic markers for complex diseases, and high dimensional variable selection for identifying important molecules for understanding molecule mechanisms in pharmacogenomics. Their applications to gene network estimation and biomarker selection are used to illustrate the methodological power. Several new challenges of Big data analysis, including complex data distribution, missing data, measurement error, spurious correlation, endogeneity, and the need for robust statistical methods, are also discussed.